Literature DB >> 10425374

Cubic phases for studies of drug partition into lipid bilayers.

S Engström1, T P Nordén, H Nyquist.   

Abstract

Drug partition into lipid bilayers in a cubic liquid-crystalline phase was investigated. Glyceryl monooleate was used to form the lipid bilayer in a reversed bicontinuous cubic liquid-crystalline phase. The reason for using the cubic phase is that it may coexist with an external aqueous phase, and that the phase boundary (cubic phase/aqueous bulk) is well-defined due to the stiffness of the cubic phase. This makes the cubic phase a potential candidate for high throughput screening (HTS) of the lipophilicity and the dissociation constant (if any) of drug compounds. Clomethiazole (CMZ), lidocaine, prilocaine and 4-phenylbutylamine (4-PBA) were chosen as model drug compounds. It was shown that it is possible to determine a pH-dependent apparent partition coefficient, Kbl/w, of a drug compound using a lipid bilayer expressed as a cubic liquid-crystalline structure. Good agreement was found when the resulting Kbl/w vs. pH curves for CMZ, lidocaine and prilocaine were fitted to a mathematical expression. This included the bilayer/water partition coefficient for the unionised and ionised drug respectively and the pKa of the drug. The effect of different experimental conditions; such as amount of cubic phase, temperature, agitation, sample preparation and interfacial area between the cubic phase and the aqueous bulk on the partition kinetics were investigated as well. The studies reveal that the time needed to reach partition equilibrium was, as expected, substantially reduced (from days to hours) by decreasing the amount of cubic phase, increasing the interfacial area between the cubic phase and the aqueous phase, and increasing the temperature and the agitation of the sample. It was also shown that the bilayer affinity of 4-PBA was increased when a zwitterionic lipid (i.e. dioleoyl phosphatidylcholine, DOPC) was incorporated in the bilayer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425374     DOI: 10.1016/s0928-0987(99)00012-3

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  8 in total

1.  Lipid-based supramolecular systems for topical application: a preformulatory study.

Authors:  Elisabetta Esposito; Nadia Eblovi; Silvia Rasi; Markus Drechsler; Giordano M Di Gregorio; Enea Menegatti; Rita Cortesi
Journal:  AAPS PharmSci       Date:  2003-11-18

2.  Preparation and characterization of pluronic-colloidal silicon dioxide composite particles as liquid crystal precursor.

Authors:  Manish Maheshwari; Anant Paradkar; Shigeo Yamamura; Shivajirao Kadam
Journal:  AAPS PharmSciTech       Date:  2006       Impact factor: 3.246

3.  Interactions of tryptophan, tryptophan peptides, and tryptophan alkyl esters at curved membrane interfaces.

Authors:  Wei Liu; Martin Caffrey
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

4.  Cubosome dispersions as delivery systems for percutaneous administration of indomethacin.

Authors:  Elisabetta Esposito; Rita Cortesi; Markus Drechsler; Lydia Paccamiccio; Paolo Mariani; Catia Contado; Elisa Stellin; Enea Menegatti; Francesco Bonina; Carmelo Puglia
Journal:  Pharm Res       Date:  2005-12       Impact factor: 4.200

5.  Oleoylethanolamide-based lyotropic liquid crystals as vehicles for delivery of amino acids in aqueous environment.

Authors:  Sayed Z Mohammady; Matthieu Pouzot; Raffaele Mezzenga
Journal:  Biophys J       Date:  2009-02-18       Impact factor: 4.033

6.  Ion exchange column technique as a novel method for evaluating the release of docetaxel from different lipid nanoparticles.

Authors:  Mohamed Dawoud; Randa Abdou
Journal:  Drug Deliv Transl Res       Date:  2021-03-25       Impact factor: 4.617

7.  Comparison of drug release from liquid crystalline monoolein dispersions and solid lipid nanoparticles using a flow cytometric technique.

Authors:  Mohamed Z Dawoud; Mohamed Nasr
Journal:  Acta Pharm Sin B       Date:  2016-01-25       Impact factor: 11.413

8.  Reverse Iontophoretic Extraction of Skin Cancer-Related Biomarkers.

Authors:  Maxim Morin; Sebastian Björklund; Skaidre Jankovskaja; Kieran Moore; Maria Begoña Delgado-Charro; Tautgirdas Ruzgas; Richard H Guy; Johan Engblom
Journal:  Pharmaceutics       Date:  2021-12-29       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.